Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Value picks for a rising dollar world

Thu, 08th Apr 2021 12:15

* European shares hit new record high

* STOXX 600 up 0.3%, FTSE 100 up 0.4%

* FOMC minutes send dovish message

* Nasdaq leads U.S. futures higher

April 8 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

VALUE PICKS FOR A RISING DOLLAR WORLD (1112 GMT)

With the rotation into value plays still underway and the
U.S. dollar on a recovery path from near one-year lows,
stockpickers way well be looking for companies that are
positively exposed to both trends.

Citi, who expects the dollar to rise further this year, has
done the job by screening out some cheap and un-crowded U.S. and
European names that have a significant positive exposure to the
greenback.

"Value has become more positively exposed to a stronger US
dollar making it the new tailwind, while the impact of interest
rates has begun to wane," they say, adding that "a strong US$ is
a headwind for Growth and Price Momentum".

Some names?

Sorted by their dollar exposure the top three buy-rated
value stocks that aren't very crowded are Syneos Health
, Aroundtown and Novartis.

Down in the list to reach position No.10 are Continental
and British American Tobacco, DISH Network
, Ahold, Deutsche Wohnen and Vodafone
and Leg Immobilien.

The influence of the dollar has increased significantly.

As you see in this Citi chart, the return correlation has
steadily risen in March to reach the highest level this year.

(Danilo Masoni)

*****

INSURERS: TAKE A LOOK AT SOLVENCY RATIOS (1033 GMT)

With shares of European insurers trading at a significant
discount to the benchmark Stoxx 600 index, the picture is
getting attractive amid rising solvency ratio estimates.

UBS says estimates for solvency ratio -- a company's ability
to meet its long-term obligations -- for the sector "increased
by +8 ppts on average since FY20 to 199% driven largely by the
increase in interest rates."

This "screens well both for downside protection but also for
potential for upside to dividend/capital return," according to
them.

With the sector trading at a 40% discount to the Eurostoxx,
compared to its historical average of 20%, this higher solvency,
along with macro tailwinds, "means the sector's capital return
screens attractive," they say.

Among single names, UBS says Generali (231%), NN Group
(216%) and Aviva (209%) standout with the highest solvency
ratios.

Chart below shows European insurer stocks
underperforming the Stoxx 600.

(Stefano Rebaudo)

*****

NEW RECORD HIGH FOR STOXX (0847 GMT)

European shares are off to a positive start this morning
with the STOXX 600 making a fresh record high in early deals and
the FTSE 100 hitting its highest in more than a year, helped by
dovish messaging from the Fed minutes.

The pan European benchmark was last up 0.3% while the UK's
top share index added 0.1%, both off initial highs.

"Investors’ risk appetite is on the rise again as the Fed
officials renewed their dovish tone yesterday by announcing that
the massive bond-buying program will continue for 'some time',”
said Pierre Veyret, analyst at ActivTrades.

"The mood has been further strengthened by Janet Yellen
confirming a $2 trillion fiscal aid plan in the US," he added.

In single stocks worth highlighting that telco M&A is back.

KPN shares are rising 2.3% after a media report said private
investors were preparing an attempt to buy the top Dutch
telecoms provider. KPN declined to comment.

(Danilo Masoni)

*****

KEEP THE FAIT (0709 GMT)

The messages from the Fed's minutes could not be clearer.
First, despite the blowout March payrolls report, labour markets
are nowhere near its threshold for reining in easy monetary
policy. And the Fed aims to let inflation average 2% for some
time before contemplating any tightening.

In short: FAIT or flexible average inflation targeting.

The message seems to have sunk in - 10-year Treasury yields
are some 10 basis points off recent highs, a spike in
short-dated yields has abated and some of the most aggressive
pricing of Fed rate hikes has been scaled back.

Markets will await Fed Chair Jay Powell's appearance at the
IMF spring meetings but the minutes have lifted U.S. equity
futures half a percent, following Wednesday's records on Wall
Street. European stocks are opening higher too, with the UK's
FTSE looking to extend its Wednesday run to record highs.

On the economy front, strong German domestic demand lifted
industrial orders for the second straight month, hot on the
heels of this week's PMI revisions that showed euro zone
business activity back in growth.

The fly -- (or the virus) -- in the ointment is of course
COVID-19 with infections surging in India, Tokyo set for
emergency measures and some evidence of blood clots linked to
the Astra Zeneca vaccine.

Key developments that should provide more direction to
markets on Thursday:

- Corporates: Holland-based Prosus sold 2% of
Chinese gaming giant Tencent for $14.7 billion in the
largest-ever block trade; Clothing retailers Asos and Uniqlo
reported robust profits, the former seeing an astonishing 275%
leap.

- Japan's consumer confidence improved in March.

- G20 finance officials to debate President Joe Biden's
minimum corporate tax plan

- Data: Euro zone, UK construction PMI; Euro zone PPI Feb;
U.S. weekly jobless numbers

- IMF/World Bank Spring Meetings: World Bank head Kristalina
Georgieva, Fed Chairman Powell, and WTO Director General Ngozi
Okonjo-Iweala to speak

- ECB: Vice President Luis de Guindos speaks

- Emerging markets: Peru, Sri Lanka central bank meetings

(Sujata Rao)

*****

EUROPEAN BOURSES SEEN ON THE BLACK AFTER FED MINUTES (0535
GMT)

In a data heavy morning, European shares are seen in the
black this morning after the Fed renewed its commitment to
keeping policy super loose even as the U.S. economy enjoys a
rapid recovery.

Fed remains wary about the ongoing risks of the pandemic and
is committed to bolstering the economy until its recovery is
more secure, according to minutes of the U.S. central bank’s
latest policy meeting.

U.S. stock futures just hit fresh record highs, while
European futures are also in positive territory.

Eyes will also be on PMI figures for the UK and the EZ,
which are due this morning.

Financial spreadbetters at IG expect London's FTSE to open
23 points higher at 6,909, Frankfurt's DAX to open 62 points
higher at 15,239 and Paris' CAC to open 27 points higher at
6,158.

(Joice Alves)

*****

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.